Ginkoum caps. 40mg # 30

Release form, composition and packaging

?

Capsules 1 capsule

dry extract of leaves of Ginkgo biloba containing the sum of flavonoids in terms of: rutin - 24%, terpene lactones - 5% 40 mg

15 pcs.

- contour cell packaging (1) - cardboard packs.

15 pcs.

- contour cell packages (2) - cardboard packs.

15 pcs.

- contour cell packages (3) - cardboard packs.

15 pcs.

- contour cell packages (4) - cardboard packs.

30 pcs.

- polymer cans (1) - cardboard packs.

60 pcs.

- polymer cans (1) - cardboard packs.

pharmachologic effect

Herbal remedy.

The action is due to the nature of its influence on metabolic processes in cells, rheological properties of blood and microcirculation, as well as on vasomotor reactions of large blood vessels.

Improves cerebral circulation and the supply of oxygen and glucose to the brain.

Has a vasodilating effect, prevents platelet aggregation.

It normalizes metabolic processes, has an antihypoxic effect on tissues.

Prevents lipid peroxidation and the formation of free radicals in cell membranes.

It has a pronounced anti-edema effect at the level of the brain and in peripheral tissues.

In various pathological conditions, it prevents an increase in the proteolytic activity of serum. ''

Indications for use

In geriatrics with disorders of attention and / or memory, mental disorders, fear, dizziness, tinnitus, sleep disorders, general malaise resulting from cerebrovascular disorders.

Contraindications for use

Reduced blood clotting, erosive gastritis, gastric ulcer and duodenal ulcer in the acute phase, acute cerebrovascular accident, acute myocardial infarction, arterial hypotension, pregnancy, lactation, children and adolescents under 18 years of age, hypersensitivity to drugs ginkgo biloba.

Dosage regimen

Inside, 40 mg 3 times / day.

Side effect

Possible: digestive disorders, headaches, allergic reactions.

Drug interactions

There are reports that the use of ginkgo biloba preparations and the simultaneous conduct of thrombolytic therapy (taking anticoagulants, antiplatelet agents, including acetylsalicylic acid) increases the risk of cerebral hemorrhage.

Application during pregnancy and lactation

Ginkgo biloba is contraindicated for use during pregnancy and lactation (breastfeeding).

The use of ginkgo biloba preparations should be avoided in the presence of risk factors for the development of intracranial hemorrhage.

Name ENG

GINKGOUM

Clinical and pharmacological group

A drug that improves cerebral and peripheral circulation

ATX code

Ginkgo biloba

Dosage

40mg

Structure

Active ingredient: Ginkgo biloba extract dry, standardized with the content of flavonol glycosides - 22-27% and terpene lactones - 5-12% 0.04 g

Excipients: MCC - 0.109 g

calcium stearate - 0.001 g.

Indications

In geriatrics with disorders of attention and / or memory, mental disorders, fear, dizziness, tinnitus, sleep disorders, general malaise resulting from cerebrovascular disorders.

Contraindications

Reduced blood clotting, erosive gastritis, gastric ulcer and duodenal ulcer in the acute phase, acute cerebrovascular accident, acute myocardial infarction, arterial hypotension, pregnancy, lactation, children and adolescents under 18 years of age, hypersensitivity to drugs ginkgo biloba.

INN / Active ingredient

dry extract of leaves of ginkgo biloba

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 3 years

Specifications

Scope of the drug

Neurology, psychiatry

Release form

Capsules

Manufacturer country

Russia

Package quantity, pcs

thirty

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Evalar

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal angioprotective agent

Anatomical and therapeutic characteristics

N06DX02 Ginkgo Biloba leaf extract

Dosage form

Capsules

Expiration date in days

1095

Package weight, g

twenty

Category

:

Mental strain

,

Memory impairment

,

Neuroprotective agents

,

Nootropic drugs

Mode of application

:

Inside, drinking a small amount of liquid, regardless of food intake. < br> If a doctor has not recommended another dosage regimen, you should adhere to the following recommendations for taking the drug. < br> For symptomatic treatment of cerebrovascular accidents: 1-2 capsules (corresponds to 40 –80 mg of standardized dry extract of ginkgo biloba) 3 times a day. The duration of the course of treatment is at least 8 weeks. < br> In case of peripheral circulation disorders: 1 capsule (corresponds to 40 mg of standardized dry extract of Ginkgo biloba) 3 times a day or 2 capsules (corresponds to 80 mg of standardized dry extract of Ginkgo biloba) 2 times in a day. The duration of the course of treatment is at least 6 weeks. < br> For vascular or involutional pathology of the inner ear:1 capsule (corresponds to 40 mg of standardized dry extract of Ginkgo biloba) 3 times a day or 2 capsules (corresponds to 80 mg of standardized dry extract of Ginkgo biloba) 2 times a day. < br> If the drug was missed or insufficient amount was taken , the subsequent administration should be carried out as indicated in this manual, without any changes.

Dosage (volume) of the substance in the preparation

:

ginkgo biloba extract dry, standardized with the content of flavonol glycosides - 22-27% and terpene lactones - 5-12% 0.04 g.

Information on technical characteristics, delivery set, country of manufacture